DNA And Gene Cloning Services Market To Reach $9.46 Billion By 2033

DNA And Gene Cloning Services Market Growth & Trends

The global DNA and gene cloning services market size is anticipated to reach USD 9.46 billion by 2033, growing at a 15.98% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising acceptance of gene therapy and advancements in DNA and gene cloning technology are factors expected to propel market growth. Moreover, the increasing demand for personalized medicine further drives market growth.

Gene cloning facilitates the development of personalized treatments by identifying specific genetic mutations responsible for diseases. By targeting these mutations through gene therapy, personalized medicine offers more effective and targeted treatment options. Integrating gene cloning technologies into personalized medicine is expected to drive further growth in the DNA and gene cloning services market. As research continues to uncover new genetic targets for therapy and diagnostics, the demand for advanced DNA cloning services will likely increase to support personalized treatment approaches.

The COVID-19 pandemic has significantly impacted the DNA and gene cloning services market. The increased demand for synthetic biology products, driven by the urgent need for COVID-19 vaccines and treatments, has accelerated research and development (R&D) in cloning technology. Moreover, despite the challenges posed by the pandemic, the DNA and gene cloning services market is expected to continue growing steadily due to the increasing adoption of novel technologies, the rising demand for gene therapies, and ongoing advancements in genetic engineering.

However, one of the primary concerns of the misuse of gene cloning and synthesis technology is the creation of harmful pathogens through synthetic biology techniques to develop bioweapons. Improper handling or disposal of synthetic DNA could lead to environmental contamination. Engineered organisms released into the environment could have ecological consequences.

 Request a free sample copy or view report summary: DNA And Gene Cloning Services Market Report

DNA And Gene Cloning Services Market Report Highlights

• The gene synthesis services segment led the market with a revenue share of 40.21% in 2024, enabling custom DNA creation without templates.

• The DNA sequencing segment led the market in 2024 with a 39.77% revenue share and is expected to grow at the fastest CAGR throughout the forecast period.

• The academic and research institutes segment dominated the market with the largest revenue share of 38.20% in 2024.

• North America DNA and gene cloning services industry dominated and accounted for the largest revenue share of 41.14% in 2024.

DNA And Gene Cloning Services Market Segmentation

Grand View Research has segmented the global DNA and gene cloning services market on the basis of service, application, end use, and region:

DNA And Gene Cloning Services Outlook (Revenue, USD Million, 2021 - 2033)

• Gene Synthesis

• Custom Cloning

• Sub-cloning

• Others

DNA And Gene Cloning Services Application Outlook (Revenue, USD Million, 2021 - 2033)

• DNA Sequencing

• Mutagenesis

• Genotyping

• Others

DNA And Gene Cloning Services End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• CMOs & CROs

DNA And Gene Cloning Services Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the DNA And Gene Cloning Services Market

• Bio-Techne

• Charles River Laboratories

• Eurofins Scientific

• GenScript

• Danaher Corporation

• Syngene International Limited

• Twist Bioscience

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Curia Global, Inc.